The use of an anti-CD3 immunotoxin to prevent the development of lymphoproliferative disease in SCID/PBL mice

Birgitta Clinchy, Ellen S. Vitetta

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Severe combined immunodeficient mice (SCID) reconstituted with normal PBLs (SCID/PBL) from Epstein-Barr virus-positive (EBV+) human donors often develop fatal human B lymphomas which resemble the EBV-induced lymphoproliferative disease (LPD) observed in immunosuppressed individuals. This phenomenon appears to be T cell dependent. In this study we used an immunotoxin (IT) prepared by conjugating the monoclonal anti-CD3 antibody, 64.1, to deglycosylated ricin A chain (dgRTA) to prevent LPD in SCID/PBL mice. We show that the incidence of LPD is greatly reduced by either a combination of in vitro treatment of PBLs followed by one in vivo treatment of the xenografted mice with 64.1-dgRTA immunotoxin or by repeated treatments in vivo with the immunotoxin. In contrast, in vitro treatment alone or in vivo treatment with only one injection of 64.1-dgRTA were less effective. As expected, this IT did not have any non-specific cytotoxic effects on already established EBV+ tumors from SCID/PBL mice. The use of this IT, therefore, represents a simple method to avoid LPD when injecting blood-containing tissues into SCID mice.

Original languageEnglish (US)
Pages (from-to)141-153
Number of pages13
JournalJournal of Immunological Methods
Volume218
Issue number1-2
DOIs
StatePublished - Sep 1 1998

Fingerprint

Immunotoxins
SCID Mice
Human Herpesvirus 4
Therapeutics
Ricin
Anti-Idiotypic Antibodies
Lymphoma
Monoclonal Antibodies
T-Lymphocytes
Injections
Incidence
Neoplasms

Keywords

  • CD3
  • Immunotoxin
  • Lymphoproliferative disease
  • SCID/PBL

ASJC Scopus subject areas

  • Biotechnology
  • Immunology

Cite this

The use of an anti-CD3 immunotoxin to prevent the development of lymphoproliferative disease in SCID/PBL mice. / Clinchy, Birgitta; Vitetta, Ellen S.

In: Journal of Immunological Methods, Vol. 218, No. 1-2, 01.09.1998, p. 141-153.

Research output: Contribution to journalArticle

@article{ab8d3be595d04a129341a46ff569746a,
title = "The use of an anti-CD3 immunotoxin to prevent the development of lymphoproliferative disease in SCID/PBL mice",
abstract = "Severe combined immunodeficient mice (SCID) reconstituted with normal PBLs (SCID/PBL) from Epstein-Barr virus-positive (EBV+) human donors often develop fatal human B lymphomas which resemble the EBV-induced lymphoproliferative disease (LPD) observed in immunosuppressed individuals. This phenomenon appears to be T cell dependent. In this study we used an immunotoxin (IT) prepared by conjugating the monoclonal anti-CD3 antibody, 64.1, to deglycosylated ricin A chain (dgRTA) to prevent LPD in SCID/PBL mice. We show that the incidence of LPD is greatly reduced by either a combination of in vitro treatment of PBLs followed by one in vivo treatment of the xenografted mice with 64.1-dgRTA immunotoxin or by repeated treatments in vivo with the immunotoxin. In contrast, in vitro treatment alone or in vivo treatment with only one injection of 64.1-dgRTA were less effective. As expected, this IT did not have any non-specific cytotoxic effects on already established EBV+ tumors from SCID/PBL mice. The use of this IT, therefore, represents a simple method to avoid LPD when injecting blood-containing tissues into SCID mice.",
keywords = "CD3, Immunotoxin, Lymphoproliferative disease, SCID/PBL",
author = "Birgitta Clinchy and Vitetta, {Ellen S.}",
year = "1998",
month = "9",
day = "1",
doi = "10.1016/S0022-1759(98)00123-9",
language = "English (US)",
volume = "218",
pages = "141--153",
journal = "Journal of Immunological Methods",
issn = "0022-1759",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - The use of an anti-CD3 immunotoxin to prevent the development of lymphoproliferative disease in SCID/PBL mice

AU - Clinchy, Birgitta

AU - Vitetta, Ellen S.

PY - 1998/9/1

Y1 - 1998/9/1

N2 - Severe combined immunodeficient mice (SCID) reconstituted with normal PBLs (SCID/PBL) from Epstein-Barr virus-positive (EBV+) human donors often develop fatal human B lymphomas which resemble the EBV-induced lymphoproliferative disease (LPD) observed in immunosuppressed individuals. This phenomenon appears to be T cell dependent. In this study we used an immunotoxin (IT) prepared by conjugating the monoclonal anti-CD3 antibody, 64.1, to deglycosylated ricin A chain (dgRTA) to prevent LPD in SCID/PBL mice. We show that the incidence of LPD is greatly reduced by either a combination of in vitro treatment of PBLs followed by one in vivo treatment of the xenografted mice with 64.1-dgRTA immunotoxin or by repeated treatments in vivo with the immunotoxin. In contrast, in vitro treatment alone or in vivo treatment with only one injection of 64.1-dgRTA were less effective. As expected, this IT did not have any non-specific cytotoxic effects on already established EBV+ tumors from SCID/PBL mice. The use of this IT, therefore, represents a simple method to avoid LPD when injecting blood-containing tissues into SCID mice.

AB - Severe combined immunodeficient mice (SCID) reconstituted with normal PBLs (SCID/PBL) from Epstein-Barr virus-positive (EBV+) human donors often develop fatal human B lymphomas which resemble the EBV-induced lymphoproliferative disease (LPD) observed in immunosuppressed individuals. This phenomenon appears to be T cell dependent. In this study we used an immunotoxin (IT) prepared by conjugating the monoclonal anti-CD3 antibody, 64.1, to deglycosylated ricin A chain (dgRTA) to prevent LPD in SCID/PBL mice. We show that the incidence of LPD is greatly reduced by either a combination of in vitro treatment of PBLs followed by one in vivo treatment of the xenografted mice with 64.1-dgRTA immunotoxin or by repeated treatments in vivo with the immunotoxin. In contrast, in vitro treatment alone or in vivo treatment with only one injection of 64.1-dgRTA were less effective. As expected, this IT did not have any non-specific cytotoxic effects on already established EBV+ tumors from SCID/PBL mice. The use of this IT, therefore, represents a simple method to avoid LPD when injecting blood-containing tissues into SCID mice.

KW - CD3

KW - Immunotoxin

KW - Lymphoproliferative disease

KW - SCID/PBL

UR - http://www.scopus.com/inward/record.url?scp=0032170351&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032170351&partnerID=8YFLogxK

U2 - 10.1016/S0022-1759(98)00123-9

DO - 10.1016/S0022-1759(98)00123-9

M3 - Article

C2 - 9819131

AN - SCOPUS:0032170351

VL - 218

SP - 141

EP - 153

JO - Journal of Immunological Methods

JF - Journal of Immunological Methods

SN - 0022-1759

IS - 1-2

ER -